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Value of MRI in patients with a clinical
suspicion of acute myocarditis
Abstract The diagnosis of myocar-
ditis is difficult and is generally one of
exclusion. Moreover, endomyocardial
biopsy (EMB) is not a sensitive tech-
nique. Magnetic resonance imaging
(MRI), however, has shown promising
results in diagnosing myocarditis. We
evaluated 20 patients with a clinical
suspicion of acute myocarditis. Tro-
ponin I levels were elevated in 17/20
patients. Cardiac catheterization
(n=13) showed no evidence of
coronary artery disease, while normal
findings were reported in all five
patients who underwent EMB. MRI
performed 9.8±7.5 days after the
onset of symptoms showed an
LV-EDV of 172±50 ml and LV-EF of
57±10%. Abnormalities on delayed
contrast-enhanced MRI were found in
15/20 patients, involving 3.7±2.1
segments using the 17-segment
model. The lateral LV wall was most
frequently involved (61% of enhanced
segments). The enhancement was
most frequently subepicardial, less
often transmural, or midwall (respec-
tively, 67%, 22%, and 11% of en-
hanced segments). Mild to moderate
systolic wall motion abnormalities
were invariably found in the abnor-
mally enhancing myocardium on
MRI. Associated pericardial effusion
was found in six, pericardial
enhancement in nine patients. In
conclusion, the present study suggests
an important role for MRI in evaluat-
ing patients with clinical suspicion
of acute myocarditis. Not only can the
myocardial damage be precisely
depicted but also concomitant
involvement of the pericardium and
impact on regional and global
ventricular function can be assessed.
Keywords Magnetic resonance
imaging . Heart . Myocarditis
Introduction
The diagnosis of myocarditis remains difficult. Myocarditis is
rarely recognized clinically, mainly because of lack of specific
clinical signs, and the diagnosis is generally one of exclusion
[1]. Myocarditis is basically an inflammation of the cardiac
muscle associated with necrosis of adjacent myocytes but
different from those seen after ischemic changes (Dallas
criteria for classification) [1]. It is most commonly caused by
viral infections, but may also result from hypersensitivity,
trauma, radiation, and chemical and physical agents [2].
Endomyocardial biopsy (EMB) is still considered the
reference technique for diagnosis of myocarditis. However,
there remain many limitations with EMB. For example, in the
Myocarditis Treatment Trial assessing 2,233 patients with
unexplained heart failure, the EMB criteria for active
myocarditis were only met in 9% of patients [3]. Myocarditis
usually presents not as a generalized but as a focal or patchy
inflammation, often not involving the right ventricle, thus
questioning the value of a right ventricular EMB [4].
Moreover, some patients have purely humoral and cytokine
mediated forms of myocarditis with little or no cellular
infiltrate. Even in postmortem hearts with provenmyocarditis,
the probability to meet the Dallas criteria with one biopsy is
only 17–28% and with more than five biopsies approximately
two-thirds of patients met the Dallas criteria [1, 3].
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Clearly EMB is not a sensitive diagnostic tool, with a
very high false negative rate, emphasizing the need formore
accurate, preferably non-invasive methods to diagnose
myocarditis. Among these, antimyosin scintigraphy and
Gallium-67 imaging have shown promise in detecting
myocyte injury. However, these methods have low specifity
and low positive predictive values [5]. Echocardiography
has a limited role in the diagnosis of myocarditis, but it can
help to identify with fulminant myocarditis at presentation.
These patients generally have thickened myocardial walls
due to edema. In some patients this increase in wall
thickness may mimic hypertrophic cardiomyopathy in early
course of the disease. Echocardiographic analysis of
changes in myocardial texture in acute myocarditis is a
new but not yet established approach. Recently, magnetic
resonance imaging (MRI) and also multidetector computed
tomography have shown promising results in the diagnosis
and follow-up of myocarditis [4, 6–13]. The aim of the
present study was to assess the MRI findings and relate
them to the clinical, technical and other imaging findings in
patients with a clinical suspicion of acute myocarditis.
Materials and methods
The patient group consisted of 20 patients (14 male) aging
39.7±12.0 years, range 21–63, referred to MRI with
presumptive, clinical diagnosis of myocarditis (Table 1).
All studies were performed according to the guidelines of the
hospital committee on medical ethics and clinical investiga-
tion and all subjects gave informed consent for the study.
All MRI studies were performed on a 1.5-T Intera CV
MRI unit (Philips Medical Systems, Best, The Nether-
lands) with Powertrak 6,000 gradients (30 mT/m, 220 µs
rise time), a dedicated cardiac software package and the
standard five-element Synergy cardiac coil and VectorCar
dioGram possibilities. Imaging was started with acquisition
of survey scans in three orthogonal planes to localize the
heart within the chest. Afterwards, real-time interactive
scanning was used to determine the intrinsic cardiac axes.
Next, cine MRI was performed in the cardiac short-axis,
vertical long-axis and horizontal long-axis plane, using a
breath-hold balanced fast field echo sequence. Sequence
parameters were TR 3.6 ms, TE 1.8 ms, flip angle 60°, slice
thickness 8 mm, matrix 160×256, field of view 300 mm,
FOV: 80%, number of phases: 30. Depending on the heart
rate, this breath-hold acquisition, acquired at end inspira-
tion, took 10–15 s. Cardiac short-axis slices encompassed
the entire left ventricle (LV). Next, T2-short-tau inversion-
recovery fast spin-echo MRI was performed in the cardiac
short-axis (TR: 2 heart beats, TE: 100 ms, slice thickness:
8 mm, field-of-view: 320 mm, matrix: 256×256, rectan-
gular FOV: 80). Finally, inversion recovery contrast
enhanced MRI was performed after intravenous injection
of gadopentetate dimeglumine (0.2 mmol/kg body weight),
using a three-dimensional T1-weighted turbo-field echo
Table 1 Patient characteristics (ACP acute chest pain, ST ST segment elevation (↑) or depression (↓), T- negative Twaves, NA not available,
Nl normal)
Patient no. Age Sex Symptoms ECG findings Coronary angiography Biopsy result
1 32 M ACP, Left arm pain Nl NA Nl
2 35 M ACP ST↑:D1,aVL;T-:D3,aVF,V5,V6 Nl NA
3 49 M Sudden cardiac arrest ST↓:V2-V6; Nl NA
4 24 M Dyspnea Incomplete RBBB NA Nl
5 19 F Viral syndrome, acute epigastric pain ST↑:V1-V3; ST↓:V5-V6;T-:D3,aVF NA NA
6 34 M ACP T-:V1-V6 Nl NA
7 39 M ACP T-:aVL Nl NA
8 53 F ACP T-:V2-V5 Nl NA
9 29 M ACP T-:D2,D3,aVF NA NA
10 33 M ACP Nl Nl NA
11 47 F ACP Nl Nl Nl
12 58 M Acute epigastric pain T-:D3,aVF NA NA
13 40 M Cardiogenic shock ST↓:V1-V3;LBBB Nl Nl
14 42 F ACP, Left shoulder pain T-:D3 Nl NA
15 26 M ACP Nl Nl NA
16 54 M ACP, Acute dyspnea T-:D1,D2,aVL,aVF Nl NA
17 63 F Left arm pain Atrial fibrillation,LAFB NA NA
18 31 F ACP T-:D3 NA NA
19 36 M Fever, sore throat ST↑:D1,aVL; T-:D1,aVL,V5-V6 Nl NA
20 50 M ACP T-:D1,aVL,V5-V6 Nl Nl
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technique in the cardiac short-axis and long-axis planes
(TR 4.5 ms, TE 1.3 ms, flip angle 15°, slice thickness
10 mm, matrix 128×256, field of view 350 mm). The
inversion time was adjusted for optimal suppression of
normal myocardial signal (inversion time approximately
200–300 ms), and the images were obtained within 10–
20 min after injection of gadolinium.
In 19/20 patients, a transthoracic echocardiography was
performed. In 13 of the 20 patients, an additional coronary
angiography was performed to exclude coronary artery
disease. In young patients, unnecessary coronary angio-
graphies were avoided. In only five patients, a RV EMB
was performed.
MRI analysis
For assessment of global LV function, the slice-summation
technique was used. The endocardial contours of all short-
axis cine MR images encompassing the left ventricle were
delineated at end diastole and end systole, enabling
calculation of end-diastolic and end-systolic volumes, stroke
volumes, and ejection fractions. Regional LV function was
assessed using the 17-segment model as defined by the
American Society of Echocardiography [14]. Systolic wall
motion was described as normokinetic (N), slightly (H+),
moderate (H++), severely hypokinetic (H+++), akinetic (A),
or dyskinetic (D). Myocardial edema was defined as
increased signal intensity [+2 standard deviations (SDs)
above the signal intensity of normal myocardial tissue] on
T2-weighted STIR fast spin-echo. A similar approach was
used to define abnormal myocardial enhancement on late-
enhancement MRI, and the location of enhancement wihin
the myocardium was described as subendocardial, midwall,
subepicardial or transmural. Presence of myocardial edema
and abnormalities on late-enhancement MRI were segmen-
tally described using the 17-segment model [14]. Also,
images were analyzed for RVenhancement. TheMR images
were also analyzed for the presence of concomitant pericar-
dial effusion, and enhancement of the pericardial layers on
late-enhancement MRI. All results are shown as mean±SD.
Table 2 Troponin I levels, number of wall segments involved on
T2-weighted short-tau inversion-recovery (T2w-STIR) turbo spin
echo (TSE ) and delayed contrast-enhanced MRI (DE-MRI ), number
of days between onset of symptoms and MRI, end-diastolic volume


















1 5.04 1 3 3 165 66
2 12.5 NA 7 2 109 61
3 14.6 NA 2 25 245 48
4 11.8 3 7 21 264 44
5 28.2 NA 4 4 126 49
6 5.6 NA 6 3 209 52
7 3.1 4 4 2 244 54
8 0 0 1 3 103 61
9 28.4 0 2 14 160 75
10 2.41 0 2 11 209 64
11 7.4 1 1 10 156 65
12 0 1 1 21 127 57
13 8.91 3 4 5 167 31
14 15 0 0 11 144 56
15 0 0 0 5 223 57
16 6.3 0 0 5 236 48
17 0.91 0 0 15 141 55
18 21 0 0 5 113 76
19 10.2 2 6 22 147 55
20 7 2 5 8 145 61
Mean 9.7 2.1 3.7 9.8 172 57
SD 8.6 1.1 2.1 7.5 50 10
aMean and SD are calculated solely on the patients showing
abnormalities on T2-STIR TSE or DE-MRI
Table 3 Comparison between presence of wall motion abnormalities
on transthoracic echocardiography and MRI (H+, H++, H+++:
hypokinesia mild, moderate and severe, respectively; Nl normal, NA
not available, US cardiac ultrasonography)
Patient no. Wall motion US Wall motion MRI
1 Nl 6, 12, 16 H+
2 Nl 1, 7 (H++)
3 Nl Diffuse (H+), 5 (H++)
4 Nl 13, 14 (H++)
5 Nl 1 H+, 5 H++
6 Nl 7, 13 H(+)
7 Nl 5, 6 H(+)
8 Nl 4 H(+)
9 Nl 10, 11 H(++)
10 Nl 2 H(+)
11 Nl 16 H(+)
12 Nl 15 H(++)
13 Diffuse H+++ 2, 5, 6, 17 (H+++)
14 8, 13 H+ Nl
15 Nl Nl
16 Diffuse H+ 5 (H+)
17 Nl Nl
18 Nl Nl
19 NA 5, 6, 11, 12 (H+)
20 Nl 5, 6, 11, 12 (H+)
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Results
As shown in Table 1, acute chest pain was the most
common clinical presentation (13/20 patients), often
resembling ischemia-like chest pain. An obvious viral
syndrome was only present in 2/20 patients. ECG findings
ranged from normal (n=4), non-specific abnormalities
(n=2), to ST-segment depression (n=3), ST-segment
elevation (n=3), and negative T-waves (n=10) mostly in
the inferolateral LV wall (n=13), less frequently anterior
(n=2). Coronary angiography performed in 13/20 patients,
showing minimal atherosclerotic abnormalities in three
patients but no signicificant coronary artery stenoses.
Increased troponin I levels were found in 17/20 patients
(9.7±8.6 μg/l) (Table 2). Right heart EMB performed in
5/20 patients did not reveal any specific abnormalities.
Cardiac MRI findings
The average duration between symptom onset and MRI
examwas 9.8±7.5 days. Mean LVend-diastolic volume was
172±50ml, range 103–264.Mean ejection fraction was 57±
10%, range 31–76. Regional wall motion abnormalities were
found on MRI in 16 of the 20 patients whereas on
echocardiography only in three of the 19 patients (Table 3).
In 15 of the 16 patients, there was a match between regional
functional abnormalities andDE. If regional dysfunctionwas
present, contractile abnormalities were usually mild to
moderate. Akinesia or dyskinesia was never found.
Fifteen of the 20 patients displayed abnormal myocardial
enhancement on DE-MRI (Tables 2, 4). The subepicardial
myocardial region was the most frequent site of DE (67%
of enhanced segments), less common were midwall and
transmural enhancement (Figs. 1, 2). In some patients, the
pattern of DE differed according the position within the left
ventricle, i.e., midwall involvement in the ventricular
septum and subepicardial involvement in lateral LV wall.
Even though some patients showed transmural (usually
patchy) enhancement, there was never isolated subendo-
cardial DE. According to the 17-segment model, the lateral
LV wall (segments 5, 6, 11, 12, 16) was most frequently
involved, i.e., 32 of 55 segments with DE (Fig. 3).
Involvement of the interventricular septum was found in
two patients, presenting as a focal midwall enhancement
(Fig. 3). Six patients presented a minor to mild amount of
pericardial fluid, while in nine patients DE of the
pericardial layers was found. In no patients was right
ventricular DE found. In 8/16 patients, increased myocar-
dial signal intensity was found on T2-weighted-STIR
images. Though the spatial extent of abnormalities was less
extensive than on delayed contrast-enhanced MRI (2.1±1.1
segments versus 3.7±2.1 segments), in 7/8 patients a good
match in location was found with DE (Fig. 4).
Four patients showed increased troponin I levels without
DE, two patients had evidence of DE without increased
troponin I levels. There was no relation between the
increase in troponin I levels and presence and extent of DE.
The size of the group of patients with increased troponin I
levels without DE was too small to look for statistical
Table 4 MRI findings of
patient population (Myocardial
segments and regions displaying
pathological signal in T2 STIR
and DE images, pericardial
enhancement and fluid; MW
midwall, NA not available,




Patient no. Segment number T2w-STIR Segment number DE Location of DE PE PF
1 6 6, 12, 16 SEP + Nl
2 NA 1, 5, 6, 7, 12, 13, 15 SEP + +
3 NA 5, 11 SEP, TM (11) + Nl
4 11, 12, 13 1, 2, 5, 6, 11, 12, 13 SEP, TM (13) + +
5 NA 4, 5, 11, 12 TM Nl +
6 NA 7, 9, 12, 13, 14, 16 SEP, MW (7, 9, 13, 14) + +
7 5, 6, 11, 12 5, 6, 11, 12 SEP Nl Nl
8 Nl 4 SEP Nl Nl
9 NA 10, 11 TM Nl Nl
10 Nl 2, 3 MW + Nl
11 16 16 SEP Nl Nl
12 15 15 SEP + +
13 13, 16, 17 4, 5, 13, 17 TM + Nl
14 Nl Nl Nl Nl Nl
15 Nl Nl Nl Nl +
16 Nl Nl Nl Nl Nl
17 Nl Nl Nl Nl Nl
18 Nl Nl Nl Nl Nl
19 8, 14 4, 5, 6, 11, 12, 16 SEP Nl Nl
20 4, 5 4, 5, 10, 11, 16 SEP + Nl
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significant differences in global and regional function with
the group with increased enzyme levels and with DE.
All patients received supportive, anti-inflammatory and
if necessary anti-arrhythmic and heart failure treatment.
Clinical follow-up at 6 months, available for 18 patients,
was uneventful for 15 patients, while three patients showed
a relapse of myocarditis, respectively at 1, 3 and 5 months.
Discussion
Using a comprehensive MRI approach in patients with a
clinical suspicion of acute myocarditis, a pattern of
abnormalities is found that seems to be quite specific and
thus might enable to differentiate it from other myocardial
diseases, in particular ischemic heart disease. Most typically
is the enhancement of the subepicardial part of the LV lateral
wall. Not infrequently the enhancement extends beyond the
outer borders of the myocardium into the adjacent pericar-
dium (“peri-myocarditis”) often associated with a minor/
mild pericardial effusion. Extension of the lateral wall
enhancement anteriorly or inferiorly is common. Septal
enhancement, although relatively rare, is shown as linear
midwall enhancement with normal appearance of the
subendocardial layers on both sides of the ventricular
septum. In the current study group, no right ventricular
myocardial wall enhancement was found, most likely
explaining the “false” negative findings on EMB. Function-
ally, regional contraction abnormalities are invariably
present in the areas with wall enhancement but are visually
scored as mildy to moderately hypokinetic. The impact on
global ventricular function is usually limited with low-
normal to mildly decreased ejection fractions, and normal to
mildly increased end-diastolic ventricular volumes.
These findings are in agreement with previous reports
using DE-MRI to study patients with clinical suspicion
with acute myocarditis [4, 9–12]. The location of enhance-
ment within the wall and throughout the ventricles seems to
be fairly specific for myocarditis. Presence of subepicardial
and midwall enhancement is highly suspicous for myocar-
Fig. 1a, b Acute myocarditis in
a 35-year old male presenting
with acute chest pain, showing
normal coronary arteries.
Delayed enhancement MRI
shows a strong subepicardial
enhancement in the anterolateral
LV wall as shown in the short-
axis view (white arrows), b the
spread in longitudinal direction
can be well appreciated on
the vertical long-axis view
(white arrows)
Fig. 2a, b Acute myocarditis in
a 33-year-old male presenting
with acute chest pain. DE-MRI
shows strong midwall enhance-
ment in the basal part of the
ventricular septum (segment 2,
3) as shown in a the horizontal
long-axis image (black arrow),
and b cardiac short-axis (white
arrows)
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ditis in a patient with clinical suspicion for myocarditis, and
always enables exclusion of ischemia-related myocardial
damage, since this disease starts in the subendocardium and
spreads like a wavefront in the transmural direction [9].
Moreover, the lateral wall and less frequently the (basal)
ventricular septum are most commonly involved. Although
speculative and definitely not proven, it might be postulated
that one of the reasons for subepicardial involvement in
lateral LV wall might be direct extension from the adjacent
pericardial sac, that at this location is very near the LV
myocardium. Eventually, the pericardial sac may act as an
intermediate between left lung/pleural space and myocardi-
um. Although in the current study population there was no
evidence of concomitant pulmonary infection, nine of 20
patients showed some degree of enhancement of the
pericardial layers, indicating an inflammatory reaction,
which may coincide or eventually precede the myocardial
involvement [12, 15]. Another hypothesis may be related to
lower wall stresses in the subepicardial part of the myocar-
dium. In a recent study, Mahrholdt and co-workers found a
relationship between the type of virus and pattern of
myocardial damage, as well as the clinical course [12].
Presence of increased signal on T2-weighted STIR
imaging is indicative of increased myocardial water content
(“myocardial edema”) and is, for example, typically found in
patients with a new myocardial infarction [16, 17]. More-
over, the extent is significantly larger than the area of
necrosis [16]. In our study group, in less than 50% of patients
abnormalities were found on T2-weighted STIR imaging,
and the extent was less extensive than the DE area. Since the
pathophysiological mechanism is different, this might
explain the observed differences with less extensive edema
in patients with acute myocarditis. Complete or partial
resorption of myocardial edema between onset of symptoms
and MRI exam may be another potential explanation.
In 25% of patients (five patients) no abnormalities were
found neither on T2-weighted STIR nor DE imaging,
although four of five patients had an abnormal troponin I
level. In the study by Abdel-aty and co-workers, sensitivity,
specificity and accuracy of DE for the detection of acute
myocarditis were 44%, 100% and 71% respectively, in this
study nearly half of the patients showed DE [10, 18]. In the
study by Mahrholdt et al. [4], 88% of patients showed
contrast enhancement. This can be explained in several ways.
In borderline myocarditis, myocyte injury is not present and
in this group it may be possible not to see delayed contrast
enhancement. On the other hand, there are cytokine and
humoral mediated forms of myocarditis and again these
Fig. 4a–c Acute myocarditis in 39-year-old male presenting with
acute chest pain. MRI shows a close matching between the
abnormalities on T2-weighted STIR imaging and DE-MRI. a Short-
axis T2-weighted STIR image, and b short-axis DE-MRI obtained at
the same level show increased signal in the subepicardial part of the
lateral LV wall. c The abnormalities are confirmed on the horizontal
long-axis view
Fig. 3 Bulls eye representation of segments with delayed enhance-
ment (shown in parentheses)
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formsmay not display delayed enhancement. Also, virus type
can be important for the pattern of myocardial injury. The
time of theMRI study after the onset of symptoms, especially
for T2-weighted STIR imaging, may also be important.
Another remarkable finding is the lack of specifity of
transthoracic echocardiography in assessing regional wall
motion abnormality compared with cine MRI. A likely
explanation is the involvement of the lateral LV wall, often
more difficultly accessible with echocardiography, and the
mild or moderate degree of dysfunction.
The main limitation of the current study is the lack of
validation of the MRI findings. As mentioned above, the
value of EMB, as the “gold standard”, is questionable unless
a targeted approach is used [4], for example, using DE-MRI
to guide your biopsy. The diagnosis of myocarditis was
therefore based on clinical signs, coronary angiography,
ECG, laboratory, enzymes and clinical follow-up.
In conclusion, cardiac MRI is an important diagnostic
tool in patients with a clinical suspicion of acute myocar-
ditis, especially in patients with unexplained chest pain,
elevated cardiac enzymes and normal coronary arteries.
Not only does it allow detection of the presence and extent
of myocardial damage but it also allows differentiation of
other entities (e.g., ischemia-related), to detect the presence
of concomitant pericardial involvement and to quantify the
impact on regional and global function. However, it should
be emphasized that a considerable number of patients have
normal MRI findings despite increased enzyme levels and
ECG abnormalities. Further research is necessary to better
understand and categorize these MRI-negative patients.
Finally, comprehensive MRI including DE can be used to
follow-up patients with acute myocarditis, and also to
better understand the underlying mechanisms of the
evolution towards heart failure in some patients [12, 19].
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